PROVENTION BIO INC (PRVB)
US74374N1028 - Common Stock
| 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 44.04M | 78.19M | 102.30M | 39.20M | 58.50M | |||
| Marketable Securities | 120.96M | 16.92M | 19.50M | 46.20M | N/A | |||
| Receivables | 1.36M | N/A | N/A | N/A | N/A | |||
| Inventories | 1.23M | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 7.06M | 5.99M | 4.70M | 600.00K | 3.00M | |||
| Total Current Assets | 174.65M | 101.10M | 126.60M | 86.00M | 61.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.53M | 2.38M | 1.80M | N/A | N/A | |||
| Investments And Advances | 0.00 | 32.02M | N/A | N/A | N/A | |||
| Intangibles | 59.56M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 120.00K | 120.00K | 100.00K | N/A | N/A | |||
| Total Non-Current Assets | 62.21M | 34.52M | 1.90M | 0.00 | 0.00 | |||
| TOTAL ASSETS | 236.86M | 135.62M | 128.50M | 86.00M | 61.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 20.75M | 13.65M | 9.20M | 2.10M | 1.30M | |||
| Accounts Payable | 6.76M | 3.55M | 7.60M | 1.80M | 600.00K | |||
| Other Current Liabilities | 62.87M | 5.60M | N/A | N/A | N/A | |||
| Total Current Liabilities | 90.39M | 22.79M | 16.70M | 3.80M | 1.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 23.47M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.15M | 2.10M | 700.00K | N/A | 0.00 | |||
| Total Non-Current Liabilities | 24.62M | 2.10M | 700.00K | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 115.01M | 24.89M | 17.40M | 3.80M | 1.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -405.64M | -292.07M | -177.60M | -79.10M | -35.80M | |||
| Additional Paid In Capital | 528.13M | 402.94M | 288.70M | 161.20M | 95.40M | |||
| Common Shares | 9.00K | 6.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -647.00K | -139.00K | 0.00 | N/A | N/A | |||
| Shares Outstanding | 87.67M | 63.37M | 56.50M | 47.70M | 37.40M | |||
| Tangible Book Value per Share | 0.71 | 1.75 | 1.97 | 1.72 | 1.60 | |||
| Total Shareholders' Equity | 121.85M | 110.73M | 111.10M | 82.20M | 59.70M | |||
| TOTAL LIABILITIES AND EQUITY | 236.86M | 135.62M | 128.50M | 86.00M | 61.50M | |||
| Statistics | ||||||||
| Debt/Equity | 0.19 | N/A | N/A | N/A | N/A | |||
| Current Ratio | 1.93 | 4.44 | 7.58 | 22.63 | 32.37 | |||
| Return On Assets (ROA) | -47.95% | -84.38% | -76.72% | -50.34% | -43.50% | |||
| Return On Equity (ROE) | -93.20% | -103.34% | -88.73% | -52.66% | -44.81% | |||
All data in USD